DrugPatentWatch Database Preview
Details for Patent: 7,981,938
» See Plans and Pricing
Which drugs does patent 7,981,938 protect, and when does it expire?
Patent 7,981,938 protects COLCRYS and is included in one NDA.
Summary for Patent: 7,981,938
| Title: | Colchicine compositions and methods |
| Abstract: | Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed. |
| Inventor(s): | Davis; Matthew W. (Erwinna, PA) |
| Assignee: | Mutual Pharmaceutical Company, Inc. (Philadelphia, PA) |
| Application Number: | 12/687,406 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,981,938 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 7,981,938
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Takeda Pharms Usa | COLCRYS | colchicine | TABLET;ORAL | 022352-001 | Jul 29, 2009 | AB | RX | Yes | Yes | Start Trial | Start Trial | A METHOD FOR TREATMENT OF GOUT FLARES DURING PROPHYLAXIS | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
